Cision PR Newswire

Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

Median OS was extended by 8.5 months compared with platinum-based doublet chemotherapy (25.9 vs 17.4 months), with a 31% reduction in the risk...

Happy Spring Festival! Here are all the ways you can celebrate!

BEIJING, Jan. 27, 2025 /PRNewswire/ -- A news report from China.org.cn on Spring Festival: How do the Chinese celebrate the Spring Festival? If your knowledge...

MicroCloud Hologram Inc. plans to adopt deepseek R1 as the basis for holographic AI applications to provide users with holographic intelligence experience

SHENZHEN, China, Jan. 27, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, announced plans to adopt...

Bloomage Joins the United Nations Global Compact

PARSIPPANY, N.J., Jan. 27, 2025 /PRNewswire/ -- Bloomage, a global leader in hyaluronic acid and other bioactive innovations, officially joined the United Nations Global...

Lichen China Limited Announces Receipt of Notification from Nasdaq

XIAMEN, China, Jan. 27, 2025 /PRNewswire/ --Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that...